ReP USP - Resultado da busca

Artigo de periodico
IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study (2023)
Barratt, Jonathan; Rovin, Brad; Wong, Muh Geot; Alpers, Charles E; Bieler, Stewart; He, Ping; Inrig, Jula; Komers, Radko; Heerspink, Hiddo J. L; Mercer, Alex; Noronha, Irene de Lourdes
Source: Kidney international reports. Unidade: FM
Subjects: NEFROPATIAS, PESQUISA QUALITATIVA, IMUNOGLOBULINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARRATT, Jonathan et al. IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study. Kidney international reports, v. 8, n. 5, p. 1043-1056, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53820. Acesso em: 18 nov. 2024.
APA
Barratt, J., Rovin, B., Wong, M. G., Alpers, C. E., Bieler, S., He, P., et al. (2023). IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study. Kidney international reports, 8( 5), 1043-1056. doi:10.1016/j.ekir.2023.02.1086
NLM
Barratt J, Rovin B, Wong MG, Alpers CE, Bieler S, He P, Inrig J, Komers R, Heerspink HJL, Mercer A, Noronha I de L. IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study [Internet]. Kidney international reports. 2023 ; 8( 5): 1043-1056.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53820
Vancouver
Barratt J, Rovin B, Wong MG, Alpers CE, Bieler S, He P, Inrig J, Komers R, Heerspink HJL, Mercer A, Noronha I de L. IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study [Internet]. Kidney international reports. 2023 ; 8( 5): 1043-1056.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53820
Artigo de periodico
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial (2023)
Rovin, Brad H; Barratt, Jonathan; Heerspink, Hiddo J. L.; Alpers, Charles E.; Bieler, Stewart; Chae, Dong-Wan; Diva, Ulysses A.; Floege, Juergen; Gesualdo, Loreto; Inrig, Jula K.; Noronha, Irene de Lourdes
Source: LANCET. Unidade: FM
Subjects: ANGIOTENSINAS, GLOMERUNEFRITE, INSUFICIÊNCIA RENAL CRÔNICA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVIN, Brad H et al. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. LANCET, v. 402, n. 10417, p. 2077-2090, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57858. Acesso em: 18 nov. 2024.
APA
Rovin, B. H., Barratt, J., Heerspink, H. J. L., Alpers, C. E., Bieler, S., Chae, D. -W., et al. (2023). Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. LANCET, 402( 10417), 2077-2090. doi:10.1016/S0140-6736(23)02302-4
NLM
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae D-W, Diva UA, Floege J, Gesualdo L, Inrig JK, Noronha I de L. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial [Internet]. LANCET. 2023 ; 402( 10417): 2077-2090.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57858
Vancouver
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae D-W, Diva UA, Floege J, Gesualdo L, Inrig JK, Noronha I de L. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial [Internet]. LANCET. 2023 ; 402( 10417): 2077-2090.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57858
Artigo de periodico
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active- controlled clinical trial (2023)
Heerspink, Hiddo J. L; Radhakrishnan, Jai; Alpers, Charles E; Barratt, Jonathan; Bieler, Stewart; Diva, Ulysses; Inrig, Jula; Komers, Radko; Mercer, Alex; Noronha, Irene de Lourdes
Source: Lancet. Unidade: FM
Subjects: ALBUMINÚRIA, NEFROPATIAS, PROTEINÚRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEERSPINK, Hiddo J. L et al. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active- controlled clinical trial. Lancet, v. 401, n. 10388, p. 1584-1594, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54593. Acesso em: 18 nov. 2024.
APA
Heerspink, H. J. L., Radhakrishnan, J., Alpers, C. E., Barratt, J., Bieler, S., Diva, U., et al. (2023). Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active- controlled clinical trial. Lancet, 401( 10388), 1584-1594. doi:10.1016/S0140-6736(23)00569-X
NLM
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha I de L. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active- controlled clinical trial [Internet]. Lancet. 2023 ; 401( 10388): 1584-1594.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54593
Vancouver
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha I de L. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active- controlled clinical trial [Internet]. Lancet. 2023 ; 401( 10388): 1584-1594.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54593
Artigo de periodico
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial (2022)
Heerspink, Hiddo J. L; Sjostrom, C. David; Jongs, Niels; Chertow, Glenn M; Kosiborod, Mikhail; Hou, Fan Fan; McMurray, John J; Rossing, Peter; Correa-Rotter, Ricardo; Kurlyandskaya, Raisa; Noronha, Irene de Lourdes
Source: European heart journal. Unidade: FM
Subjects: DOENÇA CRÔNICA, INSUFICIÊNCIA RENAL, MORTALIDADE, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEERSPINK, Hiddo J. L et al. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. European heart journal, v. 42, n. 13, p. 1216-1227, 2022Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehab094. Acesso em: 18 nov. 2024.
APA
Heerspink, H. J. L., Sjostrom, C. D., Jongs, N., Chertow, G. M., Kosiborod, M., Hou, F. F., et al. (2022). Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. European heart journal, 42( 13), 1216-1227. doi:10.1093/eurheartj/ehab094
NLM
Heerspink HJL, Sjostrom CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJ, Rossing P, Correa-Rotter R, Kurlyandskaya R, Noronha I de L. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial [Internet]. European heart journal. 2022 ; 42( 13): 1216-1227.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/eurheartj/ehab094
Vancouver
Heerspink HJL, Sjostrom CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJ, Rossing P, Correa-Rotter R, Kurlyandskaya R, Noronha I de L. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial [Internet]. European heart journal. 2022 ; 42( 13): 1216-1227.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/eurheartj/ehab094
Artigo de periodico
The dermatophyte trichophyton rubrum induces neutrophil extracellular traps release by human neutrophils (2022)
Reis, Ana Paula Carvalho; Celestrino, Giovanna Azevedo ; Igoa, Mariana Villas Bôas ; Jesus, Thais Martins; França, Tábata Takahashi ; Moreira, Daniel Valério Silva da; Rigato, Paula Ordonhez ; Sato, Paula Keiko ; Condino Neto, Antonio ; Noronha, Irene de Lourdes ; Melicio, Luciane Alarcão Dias ; Lalwani, Pritesh Jaychand ; Benard, Gil ; Sousa, Maria Gloria Teixeira
Source: Journal of Fungi. Unidades: ICB, FM
Subjects: IMUNOLOGIA, NEUTRÓFILOS, ARTHRODERMATACEAE, DERMATOPATIAS, FUNGOS, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, Ana Paula Carvalho et al. The dermatophyte trichophyton rubrum induces neutrophil extracellular traps release by human neutrophils. Journal of Fungi, v. 8, n. 2, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.3390/jof8020147. Acesso em: 18 nov. 2024.
APA
Reis, A. P. C., Celestrino, G. A., Igoa, M. V. B., Jesus, T. M., França, T. T., Moreira, D. V. S. da, et al. (2022). The dermatophyte trichophyton rubrum induces neutrophil extracellular traps release by human neutrophils. Journal of Fungi, 8( 2), 1-9. doi:10.3390/jof8020147
NLM
Reis APC, Celestrino GA, Igoa MVB, Jesus TM, França TT, Moreira DVS da, Rigato PO, Sato PK, Condino Neto A, Noronha I de L, Melicio LAD, Lalwani PJ, Benard G, Sousa MGT. The dermatophyte trichophyton rubrum induces neutrophil extracellular traps release by human neutrophils [Internet]. Journal of Fungi. 2022 ; 8( 2): 1-9.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/jof8020147
Vancouver
Reis APC, Celestrino GA, Igoa MVB, Jesus TM, França TT, Moreira DVS da, Rigato PO, Sato PK, Condino Neto A, Noronha I de L, Melicio LAD, Lalwani PJ, Benard G, Sousa MGT. The dermatophyte trichophyton rubrum induces neutrophil extracellular traps release by human neutrophils [Internet]. Journal of Fungi. 2022 ; 8( 2): 1-9.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/jof8020147
Artigo de periodico
Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats (2022)
Silva, Filipe Miranda Oliveira; Carvalho, Priscila Oliveira de; Costalonga, Elerson C; Pepineli, Rafael; Maranhão, Raul Cavalcante ; Noronha, Irene de Lourdes
Source: Plos One. Unidades: FCF, FM
Subjects: NANOPARTÍCULAS, DIÁLISE PERITONEAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Filipe Miranda Oliveira et al. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats. Plos One, v. 17, n. 5, p. 1-15 art. e0268197, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0268197. Acesso em: 18 nov. 2024.
APA
Silva, F. M. O., Carvalho, P. O. de, Costalonga, E. C., Pepineli, R., Maranhão, R. C., & Noronha, I. de L. (2022). Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats. Plos One, 17( 5), 1-15 art. e0268197. doi:10.1371/journal.pone.0268197
NLM
Silva FMO, Carvalho PO de, Costalonga EC, Pepineli R, Maranhão RC, Noronha I de L. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats [Internet]. Plos One. 2022 ; 17( 5): 1-15 art. e0268197.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1371/journal.pone.0268197
Vancouver
Silva FMO, Carvalho PO de, Costalonga EC, Pepineli R, Maranhão RC, Noronha I de L. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats [Internet]. Plos One. 2022 ; 17( 5): 1-15 art. e0268197.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1371/journal.pone.0268197
Artigo de periodico
Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats (2022)
Castro, Leticia Urbano Cardoso; Otsuki, Denise Aya ; Sanches, Talita Rojas; Souza, Felipe Lima; Santinho, Mirela Aparecida Rodrigues; Silva, Cleonice da; Noronha, Irene de Lourdes ; Duarte Neto, Amaro Nunes ; Gomes, Samirah Abreu; Malbouisson, Luiz Marcelo Sá ; Noronha, Irene de Lourdes ; Andrade, Lucia da Conceição
Source: Scientific reports. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, CHOQUE HEMORRÁGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Leticia Urbano Cardoso et al. Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats. Scientific reports, v. 12, n. 1, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50402. Acesso em: 18 nov. 2024.
APA
Castro, L. U. C., Otsuki, D. A., Sanches, T. R., Souza, F. L., Santinho, M. A. R., Silva, C. da, et al. (2022). Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats. Scientific reports, 12( 1). doi:10.1038/s41598-022-24982-0
NLM
Castro LUC, Otsuki DA, Sanches TR, Souza FL, Santinho MAR, Silva C da, Noronha I de L, Duarte Neto AN, Gomes SA, Malbouisson LMS, Noronha I de L, Andrade L da C. Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats [Internet]. Scientific reports. 2022 ; 12( 1):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50402
Vancouver
Castro LUC, Otsuki DA, Sanches TR, Souza FL, Santinho MAR, Silva C da, Noronha I de L, Duarte Neto AN, Gomes SA, Malbouisson LMS, Noronha I de L, Andrade L da C. Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats [Internet]. Scientific reports. 2022 ; 12( 1):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50402
Artigo de periodico
Synergic renoprotective effects of combined ASC therapy with RAAS blockade in experimental advanced CKD (2022)
Maires, Marina P. C; Pereira, Krislley R; Silva, Everidiene K. V. B; Souza, Victor H. R; Teles, Flavio; Barbosa, Paulyana F; Garnica, Margoth R; Ornellas, Felipe M; Noronha, Irene de Lourdes ; Fanelli, Camilla
Source: Stem cells international. Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA, FÁRMACOS IMUNOSSUPRESSORES, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIRES, Marina P. C et al. Synergic renoprotective effects of combined ASC therapy with RAAS blockade in experimental advanced CKD. Stem cells international, v. 2022, 2022Tradução . . Disponível em: https://doi.org/10.1155/2022/5111782. Acesso em: 18 nov. 2024.
APA
Maires, M. P. C., Pereira, K. R., Silva, E. K. V. B., Souza, V. H. R., Teles, F., Barbosa, P. F., et al. (2022). Synergic renoprotective effects of combined ASC therapy with RAAS blockade in experimental advanced CKD. Stem cells international, 2022. doi:10.1155/2022/5111782
NLM
Maires MPC, Pereira KR, Silva EKVB, Souza VHR, Teles F, Barbosa PF, Garnica MR, Ornellas FM, Noronha I de L, Fanelli C. Synergic renoprotective effects of combined ASC therapy with RAAS blockade in experimental advanced CKD [Internet]. Stem cells international. 2022 ; 2022[citado 2024 nov. 18 ] Available from: https://doi.org/10.1155/2022/5111782
Vancouver
Maires MPC, Pereira KR, Silva EKVB, Souza VHR, Teles F, Barbosa PF, Garnica MR, Ornellas FM, Noronha I de L, Fanelli C. Synergic renoprotective effects of combined ASC therapy with RAAS blockade in experimental advanced CKD [Internet]. Stem cells international. 2022 ; 2022[citado 2024 nov. 18 ] Available from: https://doi.org/10.1155/2022/5111782
Artigo de periodico
Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats (2022)
Silva, E. K. V. B; Bomfim, C. G; Barbosa, A. P; Noda, P; Noronha, Irene de Lourdes ; Fernandes, Bianca Helena Ventura ; Catanozi, S.; Teodoro, Walcy Paganelli Rosolia ; Capelozzi, Vera Luiza ; Fanelli, Camilla
Source: Plos one. Unidade: FM
Subjects: COVID-19, MODELOS ANIMAIS, IMUNIZAÇÃO, ANTICORPOS, PULMÃO, PROTEÍNAS, VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, E. K. V. B et al. Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats. Plos one, v. 17, n. 5 May, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55880. Acesso em: 18 nov. 2024.
APA
Silva, E. K. V. B., Bomfim, C. G., Barbosa, A. P., Noda, P., Noronha, I. de L., Fernandes, B. H. V., et al. (2022). Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats. Plos one, 17( 5 May). doi:10.1371/journal.pone.0268434
NLM
Silva EKVB, Bomfim CG, Barbosa AP, Noda P, Noronha I de L, Fernandes BHV, Catanozi S, Teodoro WPR, Capelozzi VL, Fanelli C. Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats [Internet]. Plos one. 2022 ; 17( 5 May):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55880
Vancouver
Silva EKVB, Bomfim CG, Barbosa AP, Noda P, Noronha I de L, Fernandes BHV, Catanozi S, Teodoro WPR, Capelozzi VL, Fanelli C. Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats [Internet]. Plos one. 2022 ; 17( 5 May):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55880
Artigo de periodico
Renal amyloidosis: a new time for a complete diagnosis (2022)
Feitosa, V. A.; Neves, P. D. M. M.; Jorge, L. B.; Noronha, I. L.; Onuchic, Luiz Fernando
Source: Brazilian journal of medical and biological research. Unidade: FM
Subjects: NEFROPATIAS, DOENÇAS HEREDITÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEITOSA, V. A. et al. Renal amyloidosis: a new time for a complete diagnosis. Brazilian journal of medical and biological research, v. 55, n. 1, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50413. Acesso em: 18 nov. 2024.
APA
Feitosa, V. A., Neves, P. D. M. M., Jorge, L. B., Noronha, I. L., & Onuchic, L. F. (2022). Renal amyloidosis: a new time for a complete diagnosis. Brazilian journal of medical and biological research, 55( 1). doi:10.1590/1414-431X2022e12284
NLM
Feitosa VA, Neves PDMM, Jorge LB, Noronha IL, Onuchic LF. Renal amyloidosis: a new time for a complete diagnosis [Internet]. Brazilian journal of medical and biological research. 2022 ; 55( 1):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50413
Vancouver
Feitosa VA, Neves PDMM, Jorge LB, Noronha IL, Onuchic LF. Renal amyloidosis: a new time for a complete diagnosis [Internet]. Brazilian journal of medical and biological research. 2022 ; 55( 1):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50413
Artigo de periodico
Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study (2022)
Sandes-Freitas, Taina Veras de; Cristelli, Marina Pontello; Requiao-moura, Lucio Roberto; Andrade, Luis Gustavo Modelli de; Viana, Laila Almeida; Garcia, Valter Duro; Oliveira, Claudia Maria Costa de; Esmeraldo, Ronaldo de Matos; Lima, Paula Roberta de; Charpiot, Ida Maria Maximina Fernandes; Noronha, Irene de Lourdes
Source: Transplant international. Unidade: FM
Subjects: COVID-19, TRANSPLANTE DE RIM, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDES-FREITAS, Taina Veras de et al. Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study. Transplant international, v. 35, 2022Tradução . . Disponível em: https://doi.org/10.3389/ti.2022.10205. Acesso em: 18 nov. 2024.
APA
Sandes-Freitas, T. V. de, Cristelli, M. P., Requiao-moura, L. R., Andrade, L. G. M. de, Viana, L. A., Garcia, V. D., et al. (2022). Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study. Transplant international, 35. doi:10.3389/ti.2022.10205
NLM
Sandes-Freitas TV de, Cristelli MP, Requiao-moura LR, Andrade LGM de, Viana LA, Garcia VD, Oliveira CMC de, Esmeraldo R de M, Lima PR de, Charpiot IMMF, Noronha I de L. Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study [Internet]. Transplant international. 2022 ; 35[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/ti.2022.10205
Vancouver
Sandes-Freitas TV de, Cristelli MP, Requiao-moura LR, Andrade LGM de, Viana LA, Garcia VD, Oliveira CMC de, Esmeraldo R de M, Lima PR de, Charpiot IMMF, Noronha I de L. Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study [Internet]. Transplant international. 2022 ; 35[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/ti.2022.10205
Artigo de periodico
Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats (2021)
Pepineli, Rafael; Santana, Alexandre Chagas de; Silva, Filipe Miranda de Oliveira; Tavoni, Thauany Martins; Stolf, Noedir Antonio Groppo ; Noronha, Irene de Lourdes ; Maranhão, Raul Cavalcante
Source: Journal of Pharmacy and Pharmacology. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS, TRANSPLANTE DE ÓRGÃOS, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEPINELI, Rafael et al. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats. Journal of Pharmacy and Pharmacology, v. 73, p. 1092–1100, 2021Tradução . . Disponível em: https://doi.org/10.1093/jpp/rgab066. Acesso em: 18 nov. 2024.
APA
Pepineli, R., Santana, A. C. de, Silva, F. M. de O., Tavoni, T. M., Stolf, N. A. G., Noronha, I. de L., & Maranhão, R. C. (2021). Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats. Journal of Pharmacy and Pharmacology, 73, 1092–1100. doi:10.1093/jpp/rgab066
NLM
Pepineli R, Santana AC de, Silva FM de O, Tavoni TM, Stolf NAG, Noronha I de L, Maranhão RC. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats [Internet]. Journal of Pharmacy and Pharmacology. 2021 ; 73 1092–1100.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/jpp/rgab066
Vancouver
Pepineli R, Santana AC de, Silva FM de O, Tavoni TM, Stolf NAG, Noronha I de L, Maranhão RC. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats [Internet]. Journal of Pharmacy and Pharmacology. 2021 ; 73 1092–1100.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/jpp/rgab066
Artigo de periodico
Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats (2021)
Pepineli, Rafael; Santana, Alexandre C; Silva, Filipe M. O; Tavoni, Thauany M; Stolf, Noedir Antonio Groppo ; Noronha, Irene de Lourdes ; Maranhão, Raul Cavalcante
Source: Journal of pharmacy and pharmacology. Unidades: FM, FCF
Subjects: TRANSPLANTE DE ÓRGÃOS, COLESTEROL, DOENÇAS VASCULARES, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEPINELI, Rafael et al. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats. Journal of pharmacy and pharmacology, v. 73, n. 8, p. 1092-1100, 2021Tradução . . Disponível em: https://doi.org/10.1093/jpp/rgab066. Acesso em: 18 nov. 2024.
APA
Pepineli, R., Santana, A. C., Silva, F. M. O., Tavoni, T. M., Stolf, N. A. G., Noronha, I. de L., & Maranhão, R. C. (2021). Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats. Journal of pharmacy and pharmacology, 73( 8), 1092-1100. doi:10.1093/jpp/rgab066
NLM
Pepineli R, Santana AC, Silva FMO, Tavoni TM, Stolf NAG, Noronha I de L, Maranhão RC. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats [Internet]. Journal of pharmacy and pharmacology. 2021 ; 73( 8): 1092-1100.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/jpp/rgab066
Vancouver
Pepineli R, Santana AC, Silva FMO, Tavoni TM, Stolf NAG, Noronha I de L, Maranhão RC. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats [Internet]. Journal of pharmacy and pharmacology. 2021 ; 73( 8): 1092-1100.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/jpp/rgab066
Artigo de periodico
Design and methodology of the Aging Nephropathy Study (AGNES): a prospective cohort study of elderly patients with chronic kidney disease (2020)
Coelho, Venceslau A; Santos, Giovani GN; Avesani, Carla M; Bezerra, Cicero Italo L; Silva, Luana Cristina A; Lauar, Julia C; Lindholm, Bengt; Stenvinkel, Peter; Jacob Filho, Wilson ; Noronha, Irene de Lourdes ; Zatz, Roberto
Source: Bmc nephrology. Unidade: FM
Subjects: ENVELHECIMENTO, TRANSTORNOS COGNITIVOS, INSUFICIÊNCIA CARDÍACA, ESTUDOS PROSPECTIVOS, INSUFICIÊNCIA RENAL CRÔNICA, TRANSTORNOS DO SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Venceslau A et al. Design and methodology of the Aging Nephropathy Study (AGNES): a prospective cohort study of elderly patients with chronic kidney disease. Bmc nephrology, v. 21, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12882-020-02116-w. Acesso em: 18 nov. 2024.
APA
Coelho, V. A., Santos, G. G. N., Avesani, C. M., Bezerra, C. I. L., Silva, L. C. A., Lauar, J. C., et al. (2020). Design and methodology of the Aging Nephropathy Study (AGNES): a prospective cohort study of elderly patients with chronic kidney disease. Bmc nephrology, 21( 1). doi:10.1186/s12882-020-02116-w
NLM
Coelho VA, Santos GGN, Avesani CM, Bezerra CIL, Silva LCA, Lauar JC, Lindholm B, Stenvinkel P, Jacob Filho W, Noronha I de L, Zatz R. Design and methodology of the Aging Nephropathy Study (AGNES): a prospective cohort study of elderly patients with chronic kidney disease [Internet]. Bmc nephrology. 2020 ; 21( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12882-020-02116-w
Vancouver
Coelho VA, Santos GGN, Avesani CM, Bezerra CIL, Silva LCA, Lauar JC, Lindholm B, Stenvinkel P, Jacob Filho W, Noronha I de L, Zatz R. Design and methodology of the Aging Nephropathy Study (AGNES): a prospective cohort study of elderly patients with chronic kidney disease [Internet]. Bmc nephrology. 2020 ; 21( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12882-020-02116-w
Artigo de periodico
Adipose-derived mesenchymal stem cells modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats (2020)
Costalonga, Elerson C; Fanelli, Camilla ; Garnica, Margoth R; Noronha, Irene de Lourdes
Source: Stem cells international. Unidade: FM
Subjects: COLÁGENO, IMUNOHISTOQUÍMICA, INFLAMAÇÃO, UREMIA, CITOCINAS, DIÁLISE PERITONEAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTALONGA, Elerson C et al. Adipose-derived mesenchymal stem cells modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats. Stem cells international, v. 2020, 2020Tradução . . Disponível em: https://doi.org/10.1155/2020/3768718. Acesso em: 18 nov. 2024.
APA
Costalonga, E. C., Fanelli, C., Garnica, M. R., & Noronha, I. de L. (2020). Adipose-derived mesenchymal stem cells modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats. Stem cells international, 2020. doi:10.1155/2020/3768718
NLM
Costalonga EC, Fanelli C, Garnica MR, Noronha I de L. Adipose-derived mesenchymal stem cells modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats [Internet]. Stem cells international. 2020 ; 2020[citado 2024 nov. 18 ] Available from: https://doi.org/10.1155/2020/3768718
Vancouver
Costalonga EC, Fanelli C, Garnica MR, Noronha I de L. Adipose-derived mesenchymal stem cells modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats [Internet]. Stem cells international. 2020 ; 2020[citado 2024 nov. 18 ] Available from: https://doi.org/10.1155/2020/3768718
Artigo de periodico
Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction (2020)
Moreira, Roberto S; Irigoyen, Maria C; Capcha, Jose M. C; Sanches, Talita R; Gutierrez, Paulo S; Garnica, Margoth R; Noronha, Irene de Lourdes ; Andrade, Lucia da Conceição
Source: American journal of physiology-regulatory integrative and comparative physiology. Unidade: FM
Subjects: VASOS CORONÁRIOS, RIM, INFARTO DO MIOCÁRDIO, MIOCÁRDIO, ÓXIDO NÍTRICO, RATOS WISTAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Roberto S et al. Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction. American journal of physiology-regulatory integrative and comparative physiology, v. 318, n. 3, p. R529-R544, 2020Tradução . . Disponível em: https://doi.org/10.1152/ajpregu.00185.2019. Acesso em: 18 nov. 2024.
APA
Moreira, R. S., Irigoyen, M. C., Capcha, J. M. C., Sanches, T. R., Gutierrez, P. S., Garnica, M. R., et al. (2020). Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction. American journal of physiology-regulatory integrative and comparative physiology, 318( 3), R529-R544. doi:10.1152/ajpregu.00185.2019
NLM
Moreira RS, Irigoyen MC, Capcha JMC, Sanches TR, Gutierrez PS, Garnica MR, Noronha I de L, Andrade L da C. Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction [Internet]. American journal of physiology-regulatory integrative and comparative physiology. 2020 ; 318( 3): R529-R544.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1152/ajpregu.00185.2019
Vancouver
Moreira RS, Irigoyen MC, Capcha JMC, Sanches TR, Gutierrez PS, Garnica MR, Noronha I de L, Andrade L da C. Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction [Internet]. American journal of physiology-regulatory integrative and comparative physiology. 2020 ; 318( 3): R529-R544.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1152/ajpregu.00185.2019
Artigo de periodico
Regulatory/inflammatory cellular response discrimination in operational tolerance (2019)
Carmona, Priscila; Medina-Armenteros, Yordanka; Cabral, Amanda; Monteiro, Sandra Maria; Fonseca, Simone Goncalves; Faria, Ana Caetano; Lemos, Francine; Saitovitch, David; Noronha, Irene de Lourdes ; Kalil Filho, Jorge Elias
Source: Nephrology dialysis transplantation. Unidade: FM
Subjects: AUTOANTÍGENOS, AUTOIMUNIDADE, CITOCINAS, TOLERÂNCIA IMUNOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARMONA, Priscila et al. Regulatory/inflammatory cellular response discrimination in operational tolerance. Nephrology dialysis transplantation, v. 34, n. 12, p. 2143-2154, 2019Tradução . . Disponível em: https://doi.org/10.1093/ndt/gfz114. Acesso em: 18 nov. 2024.
APA
Carmona, P., Medina-Armenteros, Y., Cabral, A., Monteiro, S. M., Fonseca, S. G., Faria, A. C., et al. (2019). Regulatory/inflammatory cellular response discrimination in operational tolerance. Nephrology dialysis transplantation, 34( 12), 2143-2154. doi:10.1093/ndt/gfz114
NLM
Carmona P, Medina-Armenteros Y, Cabral A, Monteiro SM, Fonseca SG, Faria AC, Lemos F, Saitovitch D, Noronha I de L, Kalil Filho JE. Regulatory/inflammatory cellular response discrimination in operational tolerance [Internet]. Nephrology dialysis transplantation. 2019 ; 34( 12): 2143-2154.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/ndt/gfz114
Vancouver
Carmona P, Medina-Armenteros Y, Cabral A, Monteiro SM, Fonseca SG, Faria AC, Lemos F, Saitovitch D, Noronha I de L, Kalil Filho JE. Regulatory/inflammatory cellular response discrimination in operational tolerance [Internet]. Nephrology dialysis transplantation. 2019 ; 34( 12): 2143-2154.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/ndt/gfz114
Artigo de periodico
Alternative cutaneous substitutes based on poly(L-co-D,L-lactic acid-co-trimethylene carbonate) with schinus terebinthifolius raddi extract designed for skin healing (2019)
Komatsu, Daniel; Hausen, Moema A; Eri, Ricardo Yugi; Leal, Vinicius; Pedrini, Flavia; Yaksic, Camilo; Alves, Thais F. R; Chaud, Marco V; Fanelli, Camilla ; Noronha, Irene de Lourdes ; Duek, Eliana A. R.
Source: Acs omega. Unidade: FM
Subjects: QUEIMADURAS, CICATRIZAÇÃO, BIOMATERIAIS, EXTRATOS (FORMAS FARMACÊUTICAS), PLANTAS EXTRATIVAS, BANDAGENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOMATSU, Daniel et al. Alternative cutaneous substitutes based on poly(L-co-D,L-lactic acid-co-trimethylene carbonate) with schinus terebinthifolius raddi extract designed for skin healing. Acs omega, v. 4, n. 19, p. 18317-18326, 2019Tradução . . Disponível em: https://doi.org/10.1021/acsomega.9b02427. Acesso em: 18 nov. 2024.
APA
Komatsu, D., Hausen, M. A., Eri, R. Y., Leal, V., Pedrini, F., Yaksic, C., et al. (2019). Alternative cutaneous substitutes based on poly(L-co-D,L-lactic acid-co-trimethylene carbonate) with schinus terebinthifolius raddi extract designed for skin healing. Acs omega, 4( 19), 18317-18326. doi:10.1021/acsomega.9b02427
NLM
Komatsu D, Hausen MA, Eri RY, Leal V, Pedrini F, Yaksic C, Alves TFR, Chaud MV, Fanelli C, Noronha I de L, Duek EAR. Alternative cutaneous substitutes based on poly(L-co-D,L-lactic acid-co-trimethylene carbonate) with schinus terebinthifolius raddi extract designed for skin healing [Internet]. Acs omega. 2019 ; 4( 19): 18317-18326.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1021/acsomega.9b02427
Vancouver
Komatsu D, Hausen MA, Eri RY, Leal V, Pedrini F, Yaksic C, Alves TFR, Chaud MV, Fanelli C, Noronha I de L, Duek EAR. Alternative cutaneous substitutes based on poly(L-co-D,L-lactic acid-co-trimethylene carbonate) with schinus terebinthifolius raddi extract designed for skin healing [Internet]. Acs omega. 2019 ; 4( 19): 18317-18326.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1021/acsomega.9b02427
Artigo de periodico
Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats (2019)
Silva, Filipe M. O; Costalonga, Elerson C; Silva, Cleonice; Carreira, Ana C. O; Gomes, Samirah A; Sogayar, Mari Cleide ; Fanelli, Camilla ; Noronha, Irene de Lourdes
Source: Molecular medicine. Unidade: FM
Subjects: UREMIA, ESTRÓGENOS, PROTEÍNAS MORFOGENÉTICAS ÓSSEAS, DOENÇAS PERITONEAIS, INFLAMAÇÃO, RATOS WISTAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Filipe M. O et al. Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats. Molecular medicine, v. 25, n. 1, 2019Tradução . . Disponível em: https://doi.org/10.1186/s10020-019-0110-5. Acesso em: 18 nov. 2024.
APA
Silva, F. M. O., Costalonga, E. C., Silva, C., Carreira, A. C. O., Gomes, S. A., Sogayar, M. C., et al. (2019). Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats. Molecular medicine, 25( 1). doi:10.1186/s10020-019-0110-5
NLM
Silva FMO, Costalonga EC, Silva C, Carreira ACO, Gomes SA, Sogayar MC, Fanelli C, Noronha I de L. Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats [Internet]. Molecular medicine. 2019 ; 25( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s10020-019-0110-5
Vancouver
Silva FMO, Costalonga EC, Silva C, Carreira ACO, Gomes SA, Sogayar MC, Fanelli C, Noronha I de L. Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats [Internet]. Molecular medicine. 2019 ; 25( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s10020-019-0110-5
Artigo de periodico
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial (2019)
Ruilope, Luis M; Agarwal, Rajiv; Anker, Stefan D; Bakris, George L; Filippatos, Gerasimos; Nowack, Christina; Kolkhof, Peter; Joseph, Amer; Mentenich, Nicole; Noronha, Irene de Lourdes
Source: American journal of nephrology. Unidade: FM
Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, NEFROPATIAS, URINA, MÉTODO DUPLO-CEGO, INSUFICIÊNCIA RENAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUILOPE, Luis M et al. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial. American journal of nephrology, v. 50, n. 5, p. 345-356, 2019Tradução . . Disponível em: https://doi.org/10.1159/000503712. Acesso em: 18 nov. 2024.
APA
Ruilope, L. M., Agarwal, R., Anker, S. D., Bakris, G. L., Filippatos, G., Nowack, C., et al. (2019). Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial. American journal of nephrology, 50( 5), 345-356. doi:10.1159/000503712
NLM
Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Noronha I de L. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial [Internet]. American journal of nephrology. 2019 ; 50( 5): 345-356.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000503712
Vancouver
Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Noronha I de L. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial [Internet]. American journal of nephrology. 2019 ; 50( 5): 345-356.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000503712

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration